Project Grant HT94252410447
Award Date 5/1/24
Completion Date 4/30/27
Dollars Obligated $832K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Hershey, PA 17033, USA
Similar Awards
- The U.S. Department of Defense's Defense Health Agency has awarded a $1,255,505 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, under the Military Medical Research and Development program (CFDA 12.420). The grant, which has a performance period of July 1, 2024 to June 30, 2027, is for the development of a unique small molecule for the treatment of triple-negative breast cancer. As a leading academic medical center, Penn State has...
- The Pennsylvania State University will receive $979,599 from the Defense Health Agency through September 1, 2023 to August 31, 2026 under the Military Medical Research and Development federal grant program (CFDA 12.420). The project aims to develop a novel approach to target metabolic vulnerabilities in metastatic lung cancer. Through this funding, Penn State researchers will investigate medical solutions for cancer on the battlefield and transform healthcare for service members and the public...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) provides $2,495,419.00 to The Trustees of the University of Pennsylvania (Penn) to develop a blood-based biomarker for detecting blood-brain barrier dysfunction in traumatic brain injury. The project aims to transform healthcare for service members and the public by developing innovative medical solutions for the battlefield through July 1, 2023 to June 30, 2027....
- The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $829,986.00 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, to conduct research titled "Identifying Novel Approaches for Melanoma Prevention Using Mouse Models with Humanized Telomeres". This 3-year grant, effective September 30, 2023, aims to advance innovative biomedical research into melanoma prevention...
- Federal Project Grant Award Summary The University of Pennsylvania received a $812,487 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025, with an ultimate completion date of September 29, 2028. The award supports research titled "Modulating Liver Inflammation to Improve Outcomes in Pancreatic Cancer," to be conducted at the university's Philadelphia campus. Under this three-year...
- The University of Pennsylvania received a $2,060,500 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "VALIDATION OF NOVEL DRIVERS OF JUVENILE POLYPOSIS SYNDROME". The award period is from September 1, 2023 to August 31, 2027. Through this Project Grant, the University of Pennsylvania will perform biomedical research to investigate innovative solutions for healthcare challenges facing U.S. service...
- The University of Pennsylvania received a $777,537 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. This research award supports an investigation into the associations between blood-based neurodegenerative biomarker trajectories and the risk of epilepsy, post-traumatic epilepsy, and dementia. The project will be conducted at the University of Pennsylvania's...
- The University of Pennsylvania received a $1,159,317 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025 through June 30, 2029. The award supports the EDISYN-LFS (Early Detection in Syndromic Neoplasms for Patients with Li Fraumeni Syndrome) initiative, which focuses on developing early detection methodologies and research capabilities for cancer patients with Li Fraumeni Syndrome, a hereditary...
- The University of Pennsylvania's Clinical Practices is the recipient of a $861,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the advancement of mechanistic understanding of autoimmunity in aplastic anemia through HLA allele specificity research. The project aims to provide critical insights that could lead to improved treatments for this medical condition, with a...
- The Pennsylvania State University was awarded a $3 million Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) to conduct a randomized controlled trial from September 1, 2022 to August 31, 2026. The trial will compare Intensive Multi-Couple Therapy for Post-Traumatic Stress Disorder versus Relationship Education in military couples. Penn State will collaborate with Toronto Metropolitan University and the University of...